HFM
TMO icon

Hartford Funds Management’s Thermo Fisher Scientific TMO Stock Holding History

Hartford Funds Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,230
Closed -$612K – 105
2025
Q1 		$612K Buy
1,230
+194
+19% +$105K 0.06% 81
2024
Q4 		$539K Sell
1,036
-24
-2% -$13.2K 0.05% 83
2024
Q3 		$656K Sell
1,060
-278
-21% -$165K 0.06% 66
2024
Q2 		$740K Buy
1,338
+41
+3% +$23.5K 0.07% 54
2024
Q1 		$754K Buy
1,297
+165
+15% +$92.6K 0.07% 45
2023
Q4 		$601K Buy
1,132
+46
+4% +$22.3K 0.06% 46
2023
Q3 		$550K Buy
1,086
+36
+3% +$19.2K 0.06% 33
2023
Q2 		$548K Buy
1,050
+153
+17% +$82.6K 0.06% 27
2023
Q1 		$517K Buy
897
+15
+2% +$8.45K 0.05% 23
2022
Q4 		$486K Buy
882
+252
+40% +$134K 0.05% 23
2022
Q3 		$319K Buy
630
+163
+35% +$91.2K 0.04% 14
2022
Q2 		$253K Buy
+467
New +$257K 0.03% 14

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Hartford Funds Management's TMO Position: Q2 2025 in Review

Hartford Funds Management sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 1,230 shares — an estimated $612K sold.

Hartford Funds Management first reported a position in TMO in Q2 2022 and held it in 12 quarters. The position peaked at $754K in Q1 2024. 2,458 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

  • Hartford Funds Management reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
  • Hartford Funds Management sold 1,230 Thermo Fisher Scientific shares in Q2 2025, an estimated $612K.
  • Hartford Funds Management first reported a position in Thermo Fisher Scientific in Q2 2022 and held it in 12 quarters.
  • Hartford Funds Management's Thermo Fisher Scientific position peaked at $754K in Q1 2024.
  • 2,458 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Hartford Funds Management's 13F filing for Q2 2025, filed 7 Aug 2025.